BURGALASSI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 165
AS - Asia 153
EU - Europa 150
SA - Sud America 15
OC - Oceania 3
AF - Africa 2
Totale 488
Nazione #
US - Stati Uniti d'America 163
RU - Federazione Russa 60
IT - Italia 52
CN - Cina 45
HK - Hong Kong 45
SG - Singapore 40
BR - Brasile 14
FR - Francia 12
IN - India 11
DE - Germania 9
FI - Finlandia 4
GB - Regno Unito 4
ID - Indonesia 4
AU - Australia 3
NL - Olanda 3
AT - Austria 2
IE - Irlanda 2
AR - Argentina 1
BD - Bangladesh 1
DO - Repubblica Dominicana 1
EG - Egitto 1
IL - Israele 1
IQ - Iraq 1
JP - Giappone 1
LA - Repubblica Popolare Democratica del Laos 1
MX - Messico 1
PH - Filippine 1
PL - Polonia 1
PT - Portogallo 1
TH - Thailandia 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 488
Città #
Santa Clara 101
Hong Kong 43
Singapore 30
Hefei 20
Munich 9
Paris 9
Bengaluru 8
Florence 8
Milan 7
Ashburn 6
Bologna 6
Brescia 6
Rome 5
Jakarta 4
Milazzo 4
Beijing 3
Kent 3
Los Angeles 3
Melbourne 3
Boulder 2
Dublin 2
Fontebuona 2
Grimaldi 2
Helsinki 2
Le Cannet 2
London 2
Mumbai 2
Pavia 2
Seattle 2
São Paulo 2
Turku 2
Atlanta 1
Boqueirão 1
Boydton 1
Buenos Aires 1
Chesapeake 1
Chongqing 1
Haifa 1
Jinzhong 1
Johannesburg 1
Lauro de Freitas 1
Limeira 1
Mexico City 1
New York 1
Ninh Bình 1
Parnamirim 1
Paulista 1
Philadelphia 1
Priverno 1
Quezon City 1
Rajshahi 1
Ribeirão das Neves 1
Rio Claro 1
Rio Vermelho 1
Rio de Janeiro 1
Rishikesh 1
Salto 1
Shanghai 1
Springfield 1
St Louis 1
São Gonçalo 1
São José 1
Tokyo 1
Vientiane 1
Wandsworth 1
Warsaw 1
Xi'an 1
Totale 338
Nome #
Switching anti-CGRP(R) monoclonal antibodies in multi-assessed non-responder patients and implications for ineffectiveness criteria: A retrospective cohort study 105
Validation of the Italian version of the Cluster Headache Impact Questionnaire (CHIQ) 92
Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study 76
Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions 66
Effectiveness and tolerability of rimegepant in the acute treatment of migraine: a real-world, prospective, multicentric study (GAINER study) 51
An evolving machine-learning-based algorithm to early predict response to anti-CGRP monoclonal antibodies in patients with migraine 36
Outcomes, unmet needs, and challenges in the management of patients who withdraw from anti-CGRP monoclonal antibodies: A prospective cohort study 35
Impact of duration of chronic migraine on long‐term effectiveness of monoclonal antibodies targeting the calcitonin gene‐related peptide pathway—A real‐world study 22
Exploring the multifaceted characteristics of aura in migraine: A multicenter, cross-sectional study 17
Totale 500
Categoria #
all - tutte 1.823
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.823


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202310 0 0 0 0 0 0 0 0 0 5 4 1
2023/202435 1 2 3 7 3 3 0 7 4 2 3 0
2024/2025437 4 27 14 35 77 53 52 54 17 13 27 64
2025/202618 18 0 0 0 0 0 0 0 0 0 0 0
Totale 500